Potential roles of galectins in myeloid differentiation into three different lineages

Journal of Leukocyte Biology

Volumn 73, Issue 5, 2003, Pages 650-656

  Abedin, Mohammad J ^a   Kashio, Yumiko ^a   Seki, Masako ^a   Nakamura, Kazuhiro ^a   Hirashima, Mitsuomi ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Eosinophil; HL 60; Monocyte; Neutrophil

Indexed keywords

ALKALINE EARTH METAL; BUTYRIC ACID; ECALECTIN; GALECTIN; GALECTIN 1; GALECTIN 10; GALECTIN 2; GALECTIN 3; GALECTIN 4; GALECTIN 5; GALECTIN 7; GALECTIN 8; MESSENGER RNA; PHORBOL MYRISTATE; UNCLASSIFIED DRUG; BUTYRIC ACID DERIVATIVE; DIMETHYL SULFOXIDE; GLYCOPROTEIN; LGALS9 PROTEIN, HUMAN; LYSOPHOSPHOLIPASE; PHORBOL 13 ACETATE 12 MYRISTATE; RNA; TUMOR PROTEIN;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL STRAIN HL 60; CONTROLLED STUDY; EOSINOPHIL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; CLASSIFICATION; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; PHYSIOLOGY;

BUTYRATES; CELL DIFFERENTIATION; CELL LINEAGE; DIMETHYL SULFOXIDE; EOSINOPHILS; GALECTIN 3; GALECTINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HL-60 CELLS; HUMANS; LYSOPHOSPHOLIPASE; MONOCYTES; MYELOID CELLS; NEOPLASM PROTEINS; NEUTROPHILS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TETRADECANOYLPHORBOL ACETATE;

EID: 0037824662     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0402163     Document Type: Article

References (47)

1. Newburger, P. E., Chovaniec, M. E., Greenberger, J. S., Cohen, H. J. (1979) Functional changes in human leukemic cell line HL-60. A model for myeloid differentiation. J. Cell Biol. 82, 315-322.
2. Collins, S. J., Gallo, R. C., Gallagher, R. E. (1977) Continuous growth and differentiation of human myeloid leukemic cells in suspension culture. Nature 270, 347-349.
3. Collins, S. J., Ruscetti, F. W., Gallagher, R. E., Gallo, R. C. (1978) Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc. Natl. Acad. Sci. USA 75, 2458-2462.
4. Birnie, G. D. (1988) The HL60 cell line: a model system for studying human myeloid cell differentiation. Br. J. Cancer Suppl. 9, 41-45.
5. Tsuda, T., Fukumoto, Y., Hamamori, T., Takai, Y. (1987) Involvement of two intracellular messenger systems, protein kinase C and cyclic AMP, in the regulation of c-fos gene expression in human promyelocytic leukemia (HL-60) cells. J. Biochem. (Tokyo) 102, 1579-1583.
6. Rovera, G., Santoli, D., Damsky, C. (1979) Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc. Natl. Acad. Sci. USA 76, 2779-2783.
7. Nuzhat, A., John, F. W., Maurice, J. W. (1991) The human promyelocytic HL-60 cell line: a model of myeloid cell differentiation using dimethyl sulphoxide, phorbol ester and butyrate. Biochem. Int. 23, 591-602.
8. Boyd, A. W., Metcalf, D. (1984) Induction of differentiation in HL60 leukaemic cells: a cell cycle dependent all-or-none event. Leuk. Res. 8, 27-43.
9. Fischkoff, S. A. (1988) Graded increase in probability of eosinophilic differentiation of HL-60 promyelocytic leukemia cells induced by culture under alkaline conditions. Leuk. Res. 12, 679-686.
10. Wells, V., Mallucci, L. (1991) Identification of an autocrine negative growth factor: mouse beta-galactoside-binding protein is a cytostatic factor and cell growth regulator. Cell 64, 91-97.
11. Levi, G., Tarrab-Hazdai, R., Teichberg, V. I. (1983) Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits. Eur. J. Immunol. 13, 500-507.
12. Offner, H. (1990) Recombinant human beta-galactoside binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 28, 177-184.
13. Perillo, N. L., Marcus, M. E., Baum, L. G. (1998) Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. J. Mol. Med. 76, 402-412.
14. Ravinovich, G. A., Rubinstein, N., Fainboim, L. (2002) Unlocking the secrets of galectins: a challenge at the frontier of glyco-immunology. J. Leukoc. Biol. 71, 741-752.
15. Dunphy, J. L., Barcham, G. J., Bischof, R. J., Young, A. R., Nash, A., Meensen, E. N. (2002) Isolation and characterization of a novel eosinophil-specific galectin released into the lungs in response to allergen challenge. J. Biol. Chem. 277, 14916-14924.
16. Leffler, H. (1997) Introduction to galectins. Trends GlycoSci. Glycobiotech. 9, 9-19.
17. Barondes, S. H., Castronovo, V., Cooper, D. N. W., Cummings, R. D., Hirabayashi, J., Hughes, C., Kasai, K-I., Leffler, H., Liu, F-T. (1994) Galectins: a family of animal beta-galactoside-binding lectins. Cell 76, 597-598.
18. Rabinovich, G. A. (1999) Galectins: an evolutionarily conserved family of animal lectins with multifunctional properties; a trip from the gene to clinical therapy. Cell Death Differ. 6, 711-721.
19. Hirashima, M. (1999) Ecalectin as a T cell-derived eosinophil chemoattractant. Int. Arch. Allergy Immunol. 120, 7-10.
20. Kasai, K-I., Barondes, S. H. (1991) Human breast carcinoma cDNA encoding a galactoside-binding lectin homologous to mouse Mac-2 antigen. Gene 99, 279-283.
21. Vespa, G. N., Lewis, L. A., Kozak, K. R., Moran, M., Nguyen, J. T., Baum, L. G., Miceli, M. C. (1999) Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation. J. Immunol. 162, 799-806.
22. Inohara, H., Akahani, S., Raz, A. (1998) Galectin-3 stimulates cell proliferation. Exp. Cell Res. 245, 294-302.
23. Perillo, N. L., Pace, K. E., Scilhamer, J. J., Baum, L. G. (1995) Apoptosis of T-cells mediated by galectin-1. Nature 378, 736-739.
24. Sato, S., Ouelett, N., Pelletier, I., Simard, M., Rancourt, A., Bergeron, M. G. (2002) Role of galectin-3 as an adhesion molecule for neutrophil extravasation during streptococcal pneumonia. J. Immunol. 168, 1813-1822.
25. Inufusa, H., Nakamura, M., Adachi, T., Aga, M., Kurimoto, M., Nakatani, Y., Wakano, T., Miyake, M., Okuno, K., Shiozaki, H., Yasutomi, M. (2001) Role of galectin-3 in adenocarcinoma liver metastasis. Int. J. Oncol. 19, 913-919.
26. Nangia-Makker, P., Honjo, Y., Sarvis, R., Akahani, S., Hogan, V., Pienta, K. J., Raz, A. (2000) Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am. J. Pathol. 156, 899-909.
27. Matarrese, P., Fusco, P., Tinari, N., Natoli, C., Liu, F-T., Semeraro, M. L., Malorni, W., Iacobelli, S. (2000) Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Int. J. Cancer 15, 545-554.
28. Wada, J., Ota, K., Kumar, A., Wallner, E. I., Kanwar, Y. S. (1997) Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin. J. Clin. Invest. 99, 2452-2461.
29. Saxen, L., Sariloa, H. (1987) Early organogenesis of the kidney. Pediatr. Nephrol. 1, 385-392.
30. Yourno, J., Goldberg, J., Douglas, A. N., William, J. W. (1980) Rapid in situ cytochemical classification of CFU-C colonies in soft agar culture: permanent whole culture, preparations. J. Histochem. Cytochem. 28, 991-996.
31. Matsushita, N., Nishi, N., Seki, M., Matsumoto, R., Kuwabara, I., Liu, F-T., Hata, Y., Nakamura, T., Hirashima, M. (2000) Requirement of divalent galactoside-binding activity of ecalectin/galectin-9 for eosinophil chemoattraction. J. Biol. Chem. 275, 8355-8360.
32. Shankey, T. V. (1993) Analysis of intracellular antigens using direct antibody conjugates. In Handbook of Flow Cytometry Methods (J. P. Robinson, ed.), New York, NY, Wiley-Liss, 87.
33. Krug, N., Madden, J., Redington, A. E., Lackie, P., Djukanovic, R., Schauer, U., Holgate, S. T., Frew, A. J., Howarth, P. H. (1996) T cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma. Am. J. Respir. Cell Mol. Biol. 14, 319-326.
34. Kageshita, T., Kashio, Y., Yamauchi, A., Seki, M., Abedin, M. J., Nishi, N., Shoji, H., Nakamura, T., Ono, T., Hirashima, M. (2002) Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance. Int. J. Cancer 99, 809-816.
35. Matsumoto, R., Matsumoto, H., Seki, M., Hata, M., Asano, Y., Kanegasaki, S., Stevens, R. L., Hirashima, M. (1998) Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by lymphocytes. J. Biol. Chem. 273, 16976-16984.
36. Chabot, S., Kashio, Y., Seki, M., Shirato, Y., Nakamura, K., Nishi, N., Nakamura, T., Matsumoto, R., Hirashirna, M. (2002) Regulation of galectin-9 expression and release in Jurkat T cell line cells. Glycobiology 12, 111-118.
37. Saita, N., Goto, E., Yamamoto, T., Cho, I., Tsumori, K., Kohrogi, H., Maruo, K., Ono, T., Takeya, M., Kashio, Y., Nakamura, K., Hirashima, M. (2002) Association of galectin-9 with eosinophil apoptosis. Int. Arch. Allergy Immunol. 128, 42-50.
38. Sano, H., Hsu, D. K., Yu, I., Apgar, J. R., Kuwabara, I., Yamanaka, T., Hirashima, M., Liu, F-T. (2000) Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J. Immunol. 165, 2156-2164.
39. Le Marer, N. (2000) Galectin-3 expression in differentiating human myeloid cells. Cell Biol. Int. 24, 245-251.
40. Liu, F-T., Hsu, D. K., Zuberi, R. I., Kuwabara, I., Chi, E. Y., Handerson Jr., W. R. (1995) Expression and function of galectin-3, a beta-galactoside binding lectin, in human monocytes and microphages. Am. J. Pathol. 147, 1016-1028.
41. Dyer, K. D., Rosenberg, H. F. (2001) Transcriptional regulation of galectin-10 (eosinophil Charcot-Leyden crystal protein): a CC box (-44 to -50) controls butyric acid induction of gene expression. Life Sci. 69, 201-212.
42. Ackerman, S. J., Swaminathan, G. J., Leonidas, D. D., Savage, M. P., Patrick, S., Parry, S., Nightingale, T., Acharya, K. R. (2000) Eosinophil proteins; structural biology of Charcot-Leyden crystal protein (Galectin-10): new insights into an old protein. Respir. Med. 94, 1014-1016.
43. Spry, C. J. F. (1988) Eosinophils: A Comprehensive Review and Guide to the Scientific and Medical Literature, New York, NY, Oxford Medical, 64-65.
44. Yoshida, T., Kubota, Y., Nishimoto, M., Okada, H., Hirashima, M. (2002) CD35 expression on peripheral blood granulocytes of patients with atopie dermatitis. J. Dermatol. Sci. 28, 42-47.
45. Burg, N. D., Pillingen M. H. (2001) The neutrophil: function and regulation in innate and humoral immunity. Clin. Immunol. 99, 7-17.
46. Shimonishi, T., Miyazaki, K., Kono, N., Sabil, H., Tuneyama, K., Harada, K., Hirabayashi, J., Kasai, K., Nakanuma, Y. (2001) Expression of endogenous galectin-1 and galectin-3 in intrahepatic cholangiocarcinoma. Hum. Pathol. 32, 302-310.
47. Henno, S., Brichory, F., Langanay, T., Desrues, B., Bidon, N., Delaval, P., Ramee, M. P., Dazord, L., Caulet-Maugendre, S. (2002) Expression of Po66-CBP, a galectin-8, in different types of primary and secondary broncho-pulmonary tumors. Oncol. Rep. 9, 177-180.